Europäische Wissenschaftliche Gesellschaft




Erfolgreich durch internationale Zusammenarbeit

MORPHOLOGY, PATHOLOGY, PHYSIOLOGY

Cite as: Archiv EuroMedica. 2024. 14; 3. DOI 10.35630/2024/14/3.350

Received 05 May 2024;
Accepted 18 June 2024;
Published 24 June 2024

Analysis of proliferative growth of cervical mucosal epitheliocytes in the postmenopausal period

Bogdan Shcheglov¹ orcid id logo, Ivan Reva1 orcid id logo,
Dmitry Puga1 orcid id logo, Irina Koval1 orcid id logo,
Svetlana Shcheglova2 orcid id logo, Marina Khamoshina3 orcid id logo,
Viktor Usov1 orcid id logo, Kirill Stegniy1 orcid id logo,
Galina Reva1 email orcid id logo

¹ Far Eastern Federal University, Vladivostok, Russia
2 North-Eastern State University, Magadan, Russia
3Peoples' Friendship University of Russia, Moscow, Russia

download article (pdf)

  RevaGal@yandex.ru

ABSTRACT

Purpose: To study the proliferative growth of cervical mucosal epitheliocytes in the postmenopausal period.

Materials and Methods: Histologic analysis and immunostaining methods were used to analyze proliferative growth (n = 149). Tissue samples from postmenopausal women were examined to evaluate markers of epithelial cell proliferation and assessed by Ki-67 mitotic index.

Results: It was found that proliferative activity of cervical mucosal epitheliocytes was decreased in normal course compared to pathologic course during postmenopausal period, as shown by decreased expression of Ki-67.

Conclusion: The study of proliferative growth of cervical mucosal epitheliocytes in the postmenopausal period allows a better understanding of the processes occurring in age-related dynamics. The results obtained can be used to improve the prevention and monitoring of the cervical condition in postmenopause.

Keywords: proliferative growth, Ki-67, postmenopausal period, cervix

RELEVANCE

According to the global scientific literature, it is known that the outside of the cervix is covered with a pink-colored multilayer squamous epithelium. Four main layers of keratinocytes have been identified in the multilayer epithelium:

At the level of the external cervix, multilayered squamous epithelium is connected with cylindrical epitheliocytes. As a variant of the physiologic norm, there may be the presence of cylindrical epithelium on the surface of the cervix to the outside and around the external pharynx, which is manifested as ectopia. All newborn girls have ectopia, in the age dynamics of the cylindrical epithelium slowly transforms and turns into multilayer squamous epithelium. It is generally recognized that the transformation process is realized at the expense of reserve cells located between cylindrical epitheliocytes. They give rise to islets of multilayered squamous epithelium. Ectopia can be a consequence of a normal reaction of the organism to the intake of hormonal contraceptive drugs or in pregnancy, there can also be pathological consequences when taking hormonal drugs against the background of postmenopause in order to prolong the menopausal period and prevent sharp involution of the genitourinary tract organs. In normal women of reproductive age, the junction of multilayered and cylindrical epithelium is located in the area of the external pharynx, on the endocervix in young women, and in older women it is located inside the cervical canal. The boundary between the two types of epithelium is the zone of transformation, so it should be and is the area of most careful attention of specialists. The cervical epithelium is a highly structured multilayered system of diffusers, which have complex relationships both among themselves and with the cylindrical epithelium, located in direct contact with the multilayered epithelium.

At the same time, there are three sections in the structure of the cervix with morphologic features and different immunologic load. The peculiarities of physiological regeneration of morphologically different epithelial layers, having cells as cambium, consist in different pathways of signal induction for the direction of differentiation and specialization, requiring the study of not only plasticity, but also regularities in the system of keilons - neurohormones. It is the intermediate zone, the transformation zone that is not only the site of microbial contamination, but also the site of localization of malignizing cells. However, not only the phenotypes of cellular representatives of innate and adaptive immunity, but also their interactions under conditions of papillomavirus infection have not been studied. The authors' studies have shown that the quantitative and qualitative characteristics of the differon system, including local immunity of the mucosa of this zone have differences from more proximal sections.

Aim of the Research: To investigate the proliferative growth of cervical mucosal epitheliocytes in women’s postmenopausal period (PMP).

MATERIALS AND METHODS

We analyzed 149 biopsy specimens of cervical mucosal (CM) tissue from female patients in Primorsky Region with different age dynamics and clinical indications for invasive biopsy suspected of malignization. The study was conducted in compliance with the norms of the Declaration of Helsinki (2000, 2013) and with the permission of the local Ethical Committee of FGAOU VO FEFU. The SSSM specimens were classified by age groups in accordance with the recommendations of the International Symposium on Age Periodization in Moscow (1965) according to the protocol with entry in the medical records of form No. 043/u. The morphologic landscape was obtained using hematoxylin and eosin staining technique. The process of proliferation in the epithelial lamina was quantitatively evaluated by the mitotic index using the marker Ki-67: the number of divisions per 100 cells. The analysis of cellular changes in various PMPs in women was performed using special programs, including the LYSYS II package ("Becton Dikinson Immunocytometry system"). Graphical material was obtained using a digital camera and DPx25 software.

Results

Analysis of proliferative activity at different stages of postmenopause in women showed differences in various sections of the cervical mucosa (Figure 1; Figure 2).

Figure 1. Scheme of the cervical epithelium. Note: SSE - stratified squamous epithelium of the exocervix; CE TZ - columnar epithelium of the transformation zone; SLCE - single-layered cylindrical epithelium of the endocervix

Figure 1. Scheme of the cervical epithelium. Note: SSE - stratified squamous epithelium of the exocervix; CE TZ - columnar epithelium of the transformation zone; SLCE - single-layered cylindrical epithelium of the endocervix

Figure 2. A 63-year-old woman. Localization of Ki67 gene protein in the structures of the cervical mucosa in normal postmenopause. Immunohistochemistry with hematoxylin dyeing. Microphoto. Eq. x400

Figure 2. A 63-year-old woman. Localization of Ki67 gene protein in the structures of the cervical mucosa in normal postmenopause. Immunohistochemistry with hematoxylin dyeing. Microphoto. Eq. x400

Thus, we observed that in postmenopausal women there is an increase in receptors for progesterone, a decrease in estrogen levels is associated with a decrease in receptors for estrogens and a sharp decrease in proliferative activity in the epithelial lamina of the CM (Fig. 3).

The number of Ki67-positive cells in the pathologic course during postmenopause increases to a greater extent in the exocervical SMA compared to the norm, which can be attributed to pathogen contamination and adaptive sloughing of the epithelium on the epithelial surface, these data for norm and pathology are presented in Table 1, 2.

Figure 3. Localization of Ki67 gene protein in the structures of the cervical mucosa in the presence of polyps in the cervical mucosa. Microphoto. Immunohistochemistry. Eq. x200

Figure 3. Localization of Ki67 gene protein in the structures of the cervical mucosa in the presence of polyps in the cervical mucosa. Microphoto. Immunohistochemistry. Eq. x200

The number of cells positive for Ki-67 during the pathologic process in postmenopause increases, especially in the epithelium of the exocervical epithelium of the SMA compared to the norm. This phenomenon can be attributed to colonization of this area by pathogens and adaptive desquamation of the epithelium on the tissue surface. The corresponding data on norm and pathology are presented in Tables 1 and 2.

Table 1. Evaluation of the location and quantification of Ki-67-positive cell activity in the CM of patients with normal course of postmenopausal period

CM structures control Average Ki-67 gene activity (number of mitoses per 100 cells in %)
1 year PMP 2 year PMP 3 year PMP 4 year PMP 5 year PMP
EExocervix 3,2 2,4 2 2,9 1,2
Ttransformation zone 2,4 2,4 2,1 2,6 1,1
EEndocervix 1,8 2,4 1,9 1,5 1,1
TTotal 7,4 7,2 6 7 3,4

Table 2. Evaluation of location and quantitative characterization of Ki-67 - positive cells activity in CM of patients with pathological course of postmenopausal period

CM structures in the observation group Average activity of Ki-67 gene (number of mitoses per 100 cells in %)
1 year PMP 2 year PMP 3 year PMP 4 year PMP 5 year PMP
EExocervix 4,2 2,9 2,5 2,6 1,7
TTransformation zone 3.2 2,5 2,2 1,8 1,3
EEndocervix 2,5 2,4 1,9 1,6 0,8
TTotal 9,9 7,8 6,6 6 3,8

Based on the data, it was determined that there were differences in the exocervix at any period (average over the next 5 years after the onset of expression at 2.34% for normal vs. 2.78% for pathology), and in the transformation zone (2.4% for normal vs. 3.2% for pathology) and endocervix (1. 8% at normal vs. 2.5% at pathology) in the first year of postmenopause as a function of PMP normality and increased mean Ki-67 expression level at pathology; no differences were observed in the transformation zone and endocervix in subsequent years after the onset of postmenopause with respect to PMP progression.

Conclusion. In the course of the study, it was found that different sections of the BMS have peculiarities of regenerative potential, characterized by the activity of the Ki-67 gene, which varies in the age dynamics of the examined groups. The highest activity is observed in the exocervix area, the lowest values in the transformation zone and the lowest values are observed in the endocervix area.

Authors contributions:

The concept and design of the study - D.P. Puga, G.V. Reva, I.V. Reva

Collection and processing of material - D.P. Puga, G.V. Reva, I.V. Reva

Text writing - D.P. Puga, G.V. Reva, B.O. Shcheglov

Editing - I.P. Koval, M.B. Khamoshina, V.V. Usov, K.V. Stegniy, S.N. Shcheglova

The authors declare no conflict of interest.

References

  1. The role of chronic cervicitis and disorders of local immunity of the cervix in the etiology of undeveloped pregnancy / AI Fedorova, E. I. Novikov, E. A. Grin [et al] // Gynecology. - 2021. - Т. 23, № 6. - P. 509-515. - DOI 10.26442/20795696.2021.6.201259. (in Russian).
  2. Inflammation of the uterus and reproductive disorders in women / H. R. Shakhabova, N. V. Palieva, Y. A. Petrov, V. V. Chernavsky // Chief physician of the South of Russia. - 2022. - No 2(83). - P. 17-21. (in Russian).
  3. Barrios De Tomasi, J., Opata, M. M., & Mowa, C. N. (2019). Immunity in the Cervix: Interphase between Immune and Cervical Epithelial Cells. Journal of immunology research, 2019, 7693183. DOI: 10.1155/2019/7693183
  4. Li, C., & Hua, K. (2022). Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes. Frontiers in immunology, 13, 897366. DOI: 10.3389/fimmu.2022.897366
  5. Kaliterna, V., & Barisic, Z. (2018). Genital human papillomavirus infections. Frontiers in bioscience (Landmark edition), 23(9), 1587–1611. DOI: 10.2741/4662
  6. Tang, J., Li, M., Zhao, C., Shen, D., Liu, L., Zhang, X., & Wei, L. (2022). Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials. Viruses, 14(2), 239. DOI: 10.3390/v14020239
  7. Wahid, M., Dar, S. A., Jawed, A., Mandal, R. K., Akhter, N., Khan, S., Khan, F., Jogaiah, S., Rai, A. K., & Rattan, R. (2022). Microbes in gynecologic cancers: Causes or consequences and therapeutic potential. Seminars in cancer biology, 86(Pt 2), 1179–1189. DOI: 10.1016/j.semcancer.2021.07.013
  8. Morphological and molecular criteria of endometrial receptivity disorders in patients with infertility associated with chronic endometritis / T. A. Demura, E. A. Kogan, Y. M. Kossovich, A. L. Unanyan // Archives of Obstetrics and Gynecology. V.F. Snegirev. - 2018. - Т. 5, № 1. - P. 19-25. - DOI 10.18821/2313-8726-2018-5-1-19-25. (in Russian)
  9. Some modern aspects of the clinical course, diagnosis and treatment of inflammatory diseases of the urogenital system of women / V. V. Ryzhkov, A. A. Khazhbiev, T. I. Derevyanko [et al.] // Tavricheskiy medico-biological bulletin. - 2017. - Т. 20, No 2-2. - P. 135-139. (in Russian)]
  10. Lee, S. J., Yang, A., Wu, T. C., & Hung, C. F. (2016). Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. Journal of gynecologic oncology, 27(5), e51. DOI: 10.3802/jgo.2016.27.e51
  11. Xu, X. Q., Guo, L., Wang, X., Liu, Y., Liu, H., Zhou, R. H., Gu, J., Liu, J. B., Xu, P., Zhou, L., & Ho, W. Z. (2019). Human Cervical Epithelial Cells Release Antiviral Factors and Inhibit HIV Replication in Macrophages. Journal of innate immunity, 11(1), 29–40. DOI: 10.1159/000490586
  12. Zhang, J., Meng, S., Zhang, X., Shao, K., & Lin, C. (2022). Infiltration Patterns of Cervical Epithelial Microenvironment Cells During Carcinogenesis. Frontiers in immunology, 13, 888176. DOI: 10.3389/fimmu.2022.888176
  13. Jackson, R., Lukacs, J. D., & Zehbe, I. (2020). The Potentials and Pitfalls of a Human Cervical Organoid Model Including Langerhans Cells. Viruses, 12(12), 1375. DOI: 10.3390/v12121375
  14. Quantitative dynamics of immunocompetent cells in the structure of epithelial differons of the cervix in women of older age groups / I. Reva, B. Shcheglov, D. Puga [et al.] // Higher School: Scientific Research : Proceedings of the Interuniversity International Congress, Moscow, July 07, 2023 / Editor-in-Chief D.R. Khismatullin. Vol. 2. - Moscow: Infinity, 2023. - P. 33 - 37.


back

 



Europäische Wissenschaftliche Gesellschaft